DaVita Kidney Care, an operations division of DaVita Inc. (DVA quick quoteDVA – Free Report) recently signed a contract with the National Kidney Foundation (NKF) to launch an innovative, one-year pilot program aimed at improving health equity in kidney transplants. In particular, the new program was developed within THE BIG ASK: THE BIG GIVE platform by NKF.
This collaboration is expected to give DaVita Kidney Care a boost, which in turn can help generate more revenue for the company.
THE BIG ASK: THE BIG GIVE platform at a glance
NKF’s platform helps kidney patients and their families share the need for a kidney with their community and find a living donor. The new pilot program provides comprehensive support and tools in a virtual format, enabling NKF to provide comprehensive and in-depth training and support to patients and families seeking a kidney transplant from a living donor.
After careful selection by DaVita and NKF, the decision was made to run the pilot program in Colorado, New York, Minnesota and New Mexico. The selected states have a unique opportunity to improve health equity in kidney transplants.
Benefits of working together
To shed some light on kidney disease, more than 500,000 people in the United States are currently living with kidney failure. Without dialysis, these patients have only one way to survive and that is a transplant. There are around 100,000 patients waiting for a kidney (average waiting time of three to seven years for a deceased donor depending on location) and therefore many of these patients can benefit from living organ donation.
Image source: Zacks Investment Research
By bringing together DaVita’s nursing experience and NKF’s innovative program, patients receive the support and information they need in their search for living donors.
Market outlook
According to a report by Grand View Research, the global transplant market was worth $ 8.4 billion in 2020 and is expected to experience a CAGR of 11.5% over the forecast period (2021-2028). The increasing demand for novel tissue transplant products and organ transplants for the treatment of organ failure is a major factor in the growth of this market. Therefore, the collaboration for DaVita comes at an opportune time.
Other notable collaborations
In April, DaVita’s integrated kidney care subsidiary, VillageHealth, partnered with Blue Cross and Blue Shield of Minnesota (Blue Cross) to launch an innovative program that addresses the holistic health needs of certain eligible members suffering or ending with chronic kidney disease (CKD) kidney disease (ESKD).
In March, the company announced the extension of its collaboration with Fresenius Medical Care‘s (FMS Quick QuoteFMS – Free Report) The North American wing will deploy the latter’s NxStage home hemodialysis machines and technology to patients in the United States. In particular, the agreement supports the companies’ efforts to empower more people with kidney failure to choose home dialysis as an option.
Value for money
This Zacks company’s second (Buy) stock is up 4.2% year-to-date, while the industry is down 11.3%.
Other stocks to consider
Some other high ranking stocks from the broader medical field are there HCA Healthcare, Inc. (HCA quick offerHCA – Free report) and Include Health Corporation (EHC quick offerEHC – Free report), both have a Zacks rank of # 2. You can see The full list of current Zacks # 1 ranked (Strong Buy) stocks can be found here.
HCA Healthcare’s long-term earnings growth rate is expected to be 12.3%.
Encompass Health’s long-term earnings growth rate is projected to be 17.3%.
Bitcoin, like the internet itself, could change everything
Blockchain and cryptocurrency have sparked one of the most exciting discussion topics of a generation. Some call it the “Internet of Money” and predict that it could forever change the way money works. If that’s true, it could do for banks what Netflix did with Blockbuster and Amazon did with Sears. Experts agree that we are still in the early stages of this technology and will create multiple investment opportunities as it grows.
Zacks has just revealed 3 companies that can help investors capitalize on the explosive earnings potential of Bitcoin and the other cryptocurrencies with significantly less volatility than buying them outright.
Check Out 3 Crypto-Related Stocks Now >>
source https://dailyhealthynews.ca/davitas-dva-deal-to-aid-patients-in-kidney-transplantation-june-14-2021/
No comments:
Post a Comment